Pyruvate carboxylase deficiency type A and type C: Characterization of five novel pathogenic variants in PC and analysis of the genotype-phenotype correlation.

PC tetramerization domain biotin carboxyl carrier protein domain biotin carboxylase domain carboxyl transferase domain neurodevelopmental delay pyruvate carboxylase pyruvate carboxylase deficiency

Journal

Human mutation
ISSN: 1098-1004
Titre abrégé: Hum Mutat
Pays: United States
ID NLM: 9215429

Informations de publication

Date de publication:
06 2019
Historique:
received: 05 11 2018
revised: 22 02 2019
accepted: 04 03 2019
pubmed: 15 3 2019
medline: 31 3 2020
entrez: 15 3 2019
Statut: ppublish

Résumé

Pyruvate carboxylase deficiency (PCD) is caused by biallelic mutations of the PC gene. The reported clinical spectrum includes a neonatal form with early death (type B), an infantile fatal form (type A), and a late-onset form with isolated mild intellectual delay (type C). Apart from homozygous stop-codon mutations leading to type B PCD, a genotype-phenotype correlation has not otherwise been discernible. Indeed, patients harboring biallelic heterozygous variants leading to PC activity near zero can present either with a fatal infantile type A or with a benign late onset type C form. In this study, we analyzed six novel patients with type A (three) and type C (three) PCD, and compared them with previously reported cases. First, we observed that type C PCD is not associated to homozygous variants in PC. In silico modeling was used to map former and novel variants associated to type A and C PCD, and to predict their potential effects on the enzyme structure and function. We found that variants lead to type A or type C phenotype based on the destabilization between the two major enzyme conformers. In general, our study on novel and previously reported patients improves the overall understanding on type A and C PCD.

Identifiants

pubmed: 30870574
doi: 10.1002/humu.23742
doi:

Substances chimiques

Pyruvate Carboxylase EC 6.4.1.1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

816-827

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Auteurs

Emanuele G Coci (EG)

Department for Neuropediatrics, University Children's Hospital, Ruhr University Bochum, Bochum, Germany.
Institute for Neuropediatrics and Social Pediatrics, Hamburg, Germany.

Vytautas Gapsys (V)

Computational Biomolecular Dynamics Group, Max Plank Institute for Biophysical Chemistry, Göttingen, Germany.

Natasha Shur (N)

Division of Genetics, Albany Medical Center, Albany, New York.
Children's National Medical Center, Washington, District of Columbia.

Yoon Shin-Podskarbi (Y)

Molecular Genetics and Metabolism Laboratory, Munich, Germany.

Bert L de Groot (BL)

Computational Biomolecular Dynamics Group, Max Plank Institute for Biophysical Chemistry, Göttingen, Germany.

Kathryn Miller (K)

Division of Genetics, Albany Medical Center, Albany, New York.

Jerry Vockley (J)

Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.

Neal Sondheimer (N)

Clinical and Metabolic Genetics, The Hospital for Sick Children, Toronto, Ontario, Canada.

Rebecca Ganetzky (R)

Division of Human Genetics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.

Peter Freisinger (P)

Department of Pediatrics, Klinikum Reutlingen, Reutlingen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH